List of Schedule I controlled substances (U.S.)
This is the list of Schedule I drugs as defined by the United States Controlled Substances Act.[1] The following findings are required for drugs to be placed in this schedule:[2]
- The drug or other substance has a high potential for abuse.
- The drug or other substance has no currently accepted medical use in treatment in the United States.
- There is a lack of accepted safety for use of the drug or other substance under medical supervision.
Except as specifically authorized, it is illegal for any person:
- to manufacture, distribute, or dispense, or possess with intent to manufacture, distribute, or dispense, a controlled substance; or
- to create, distribute, dispense, or possess with intent to distribute or dispense, a counterfeit substance.[3]
Additional substances are added to the list by the Secretary of Health and Human Services pursuant to 21 CFR 1308.49.[4][5]
The complete list of Schedule I drugs follows.[1] The Administrative Controlled Substances Code Number for each drug is included.
Opioids
| ACSCN | Drug |
|---|---|
| 9815 | Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide) |
| 9601 | Acetylmethadol |
| 9602 | Allylprodine |
| 9603 | Alphacetylmethadol (except levo-alphacetylmethadol also known as levo-alpha-acetylmethadol, levomethadyl acetate, or LAAM) |
| 9604 | Alphameprodine |
| 9605 | Alphamethadol |
| 9814 | Alpha-methylfentanyl (N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl] propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-propanilido) piperidine) |
| 9832 | Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4- piperidinyl]-N-phenylpropanamide) |
| 9606 | Benzethidine |
| 9607 | Betacetylmethadol |
| 9830 | Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4- piperidinyl]-N-phenylpropanamide) |
| 9831 | Beta-hydroxy-3-methylfentanyl (other name: N-[1-(2-hydroxy-2- phenethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide) |
| 9608 | Betameprodine |
| 9609 | Betamethadol |
| 9611 | Betaprodine |
| 9612 | Clonitazene |
| 9613 | Dextromoramide |
| 9615 | Diampromide |
| 9616 | Diethylthiambutene |
| 9168 | Difenoxin |
| 9617 | Dimenoxadol |
| 9618 | Dimepheptanol |
| 9619 | Dimethylthiambutene |
| 9621 | Dioxaphetyl butyrate |
| 9622 | Dipipanone |
| 9623 | Ethylmethylthiambutene |
| 9624 | Etonitazene |
| 9625 | Etoxeridine |
| 9626 | Furethidine |
| 9627 | Hydroxypethidine |
| 9628 | Ketobemidone |
| 9629 | Levomoramide |
| 9631 | Levophenacylmorphan |
| 9813 | 3-Methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]-N-phenylpropanamide) |
| 9833 | 3-methylthiofentanyl (N-[(3-methyl-1-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide) |
| 9632 | Morpheridine |
| 9661 | MPPP (1-methyl-4-phenyl-4-propionoxypiperidine) |
| 9633 | Noracymethadol |
| 9634 | Norlevorphanol |
| 9635 | Normethadone |
| 9636 | Norpipanone |
| 9812 | Para-fluorofentanyl (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-4-piperidinyl] propanamide |
| 9663 | PEPAP (1-(-2-phenethyl)-4-phenyl-4-acetoxypiperidine |
| 9637 | Phenadoxone |
| 9638 | Phenampromide |
| 9647 | Phenomorphan |
| 9641 | Phenoperidine |
| 9642 | Piritramide |
| 9643 | Proheptazine |
| 9644 | Properidine |
| 9649 | Propiram |
| 9645 | Racemoramide |
| 9835 | Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]-propanamide |
| 9750 | Tilidine |
| 9646 | Trimeperidine |
| 9821 | Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide)[6] |
| 9547 | 3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]N-methylbenzamide) (U-47700)[7] |
| 9821 | Acetylfentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide)[8] |
| 9834 | N-(1-Phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide (furanyl fentanyl)[9] |
| 9811 | Acryl fentanyl ((N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide); Acryloylfentanyl)[10] |
| 9816 | N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide (Ortho-fluorofentanyl or 2-fluorofentanyl)[11] |
| 9822 | Butyryl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide, N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide)[12] |
| 9824 | 4-Fluoroisobutyryl fentanyl ((N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide) or Para-fluoroisobutyryl fentanyl)[13] |
| 9825 | 2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide (Methoxyacetyl fentanyl)[11] |
| 9836 | Beta-hydroxythiofentanyl (N-[1-[2-hydroxy-2-(thiophen-2-yl)ethyl]piperidin-4-yl]-N-phenylpropionamide, N-[1-[2-hydroxy-2-(2-thienyl)ethyl]-4-piperidinyl]-N-phenylpropanamide)[12] |
| 9843 | N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide (Tetrahydrofuranyl fentanyl)[11] |
| 9845 | (1-phenethylpiperidin-4-yl)-N-phenylcyclopropanecarboxamide (cyclopropyl fentanyl)[14] |
| 9840 | N-(1-phenethylpiperidin-4-yl)-N-phenylpentanamide (valeryl fentanyl)[15] |
| 9823 | N-(4-fluorophenyl)N-(1-phenethylpiperidin-4-yl)butyramide (para-fluorobutyryl fentanyl)[15] |
| 9837 | N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)butyramide (para-methoxybutyryl fentanyl)[15] |
| 9826 | N-(4-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide (para-chloroisobutyryl fentanyl)[15] |
| 9827 | N-(1-phenethylpiperidin-4-yl)-N-phenylisobutyramide (isobutyryl fentanyl)[15] |
| 9847 | N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopentanecarboxamide (cyclopentyl fentanyl)[15] |
| 9838 | N-(2-fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4-yl)acetamide (ocfentanil)[15] |
| 9850 | Fentanyl-related substances, their isomers, esters, ethers, salts and salts of isomers, esters and ethers[16] |
| 9551 | AH-7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide)) |
| 9560 | MT-45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine) |
Opium derivatives
| ACSCN | Drug |
|---|---|
| 9319 | Acetorphine |
| 9051 | Acetyldihydrocodeine |
| 9052 | Benzylmorphine |
| 9070 | Codeine methylbromide |
| 9053 | Codeine-N-Oxide |
| 9054 | Cyprenorphine |
| 9055 | Desomorphine |
| 9145 | Dihydromorphine |
| 9335 | Drotebanol |
| 9056 | Etorphine (except hydrochloride salt) |
| 9200 | Diacetylmorphine (originally sold in the US under the brand name "Heroin") |
| 9301 | Hydromorphinol |
| 9302 | Methyldesorphine |
| 9304 | Methyldihydromorphine |
| 9305 | Morphine methylbromide |
| 9306 | Morphine methylsulfonate |
| 9307 | Morphine-N-Oxide |
| 9308 | Myrophine |
| 9309 | Nicocodeine |
| 9312 | Nicomorphine |
| 9313 | Normorphine |
| 9314 | Pholcodine |
| 9315 | Thebacon |
Hallucinogenic or psychedelic substances
| ACSCN | Drug |
|---|---|
| 7249 | Alpha-Ethyltryptamine (αET) |
| 7391 | 4-bromo-2,5-dimethoxy-amphetamine (DOB) |
| 7392 | 4-Bromo-2,5-dimethoxyphenethylamine (2C-B) |
| 7396 | 2,5-dimethoxyamphetamine (DOA) |
| 7399 | 2,5-Dimethoxy-4-ethylamphetamine (DOE) |
| 7348 | 2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7), its optical isomers, salts and salts of isomers |
| 7411 | 4-methoxyamphetamine (PMA) |
| 7401 | 5-methoxy-3,4-methylenedioxyamphetamine (MMDA) |
| 7395 | 4-methyl-2,5-dimethoxyamphetamine (DOM; STP) |
| 7400 | 3,4-methylenedioxyamphetamine (MDA, Sassafrass) |
| 7405 | 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy, Molly) |
| 7404 | 3,4-methylenedioxy-N-ethylamphetamine (MDEA; MDE) |
| 7402 | N-hydroxy-3,4-methylenedioxyamphetamine (N-hydroxy MDA) |
| 7390 | 3,4,5-trimethoxyamphetamine (TMA) |
| 7431 | 5-methoxy-N,N-dimethyltryptamine (5-methoxy-3-[2-(dimethylamino)ethyl]indole; 5-MeO-DMT) |
| 7432 | Alpha-methyltryptamine (αMT) |
| 7433 | Bufotenine |
| 7434 | Diethyltryptamine (DET) |
| 7435 | Dimethyltryptamine (DMT) |
| 7439 | 5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT), its isomers, salts and salts of isomers |
| 7260 | Ibogaine |
| 7315 | Lysergic acid diethylamide (LSD) |
| 7360 | Marijuana, including cannabis resin |
| 7350 | Marijuana extracts; cannabinoids[17] |
| 7381 | Mescaline |
| 7374 | Parahexyl |
| 7415 | Peyote |
| 7482 | N-ethyl-3-piperidyl benzilate |
| 7484 | N-methyl-3-piperidyl benzilate |
| 7437 | Psilocybin |
| 7438 | Psilocin |
| 7370 | Tetrahydrocannabinol (THC) |
| 7455 | Ethylamine analog of phencyclidine (Eticyclidine; PCE) |
| 7458 | Pyrrolidine analog of phencyclidine (PCPy) |
| 7470 | Thiophene analog of phencyclidine (TCP) |
| 7473 | 1-[1-(2-thienyl)cyclohexyl]pyrrolidine (TCPy) |
| 1248 | 4-methylmethcathinone (Mephedrone) |
| 7535 | 3,4-methylenedioxypyrovalerone (MDPV) |
| 7509 | 2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E) |
| 7508 | 2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D) |
| 7519 | 2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C-C) |
| 7518 | 2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C-I) |
| 7385 | 2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-2) |
| 7532 | 2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-4) |
| 7517 | 2-(2,5-Dimethoxyphenyl)ethanamine (2C-H) |
| 7521 | 2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine (2C-N) |
| 7524 | 2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine (2C-P) |
| 7540 | 3,4-Methylenedioxy-N-methylcathinone (methylone) |
| 7538 | 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25I-NBOMe; 2C-I-NBOMe; 25I; Cimbi-5)[18] |
| 7537 | 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25C-NBOMe; 2C-C-NBOMe; 25C; Cimbi-82)[18] |
| 7536 | 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25B-NBOMe; 2C-B-NBOMe; 25B; Cimbi-36)[18] |
Depressants
| ACSCN | Drug |
|---|---|
| 2010 | gamma-Hydroxybutyric acid (GHB; sodium oxybate; sodium oxybutyrate) except formulations in an FDA-approved drug product are Schedule III |
| 2572 | Mecloqualone |
| 2565 | Methaqualone |
Stimulants
| ACSCN | Drug |
|---|---|
| 1585 | Aminorex (aminoxaphen; 2-amino-5-phenyl-2- oxazoline; or 4,5-dihydro-5-phenly-2-oxazolamine) |
| 7493 | N-benzylpiperazine (some other names: BZP; 1-benzylpiperazine), its optical isomers, salts and salts of isomers |
| 1235 | Cathinone |
| 1503 | Fenethylline |
| 1237 | Methcathinone (Some other names: 2-(methylamino)-propiophenone; alpha-(methylamino)propiophenone; 2-(methylamino)-1-phenylpropan-1-one; alpha-N-methylaminopropiophenone; monomethylpropion; ephedrone; N-methylcathinone; methylcathinone; AL-464; AL-422; AL-463 and UR1432), its salts, optical isomers and salts of optical isomers |
| 1590 | (±)-cis-4-methylaminorex |
| 1475 | N-ethylamphetamine |
| 1480 | N,N-dimethylamphetamine (also known as N,N-alpha-trimethyl-benzeneethanamine; N,N-alpha-trimethylphenethylamine) |
| 7543 | N-Ethylpentylone (ephylone, N-1-(1,3-benzodioxol-5-yl)-2-(ethylamino)-1-pentanone))[19] |
| 7246 | N-Ethylhexedrone[20] |
| 7544 | alpha-Pyrrolidinohexanophenone (α-PHP)[20] |
| 7245 | 4-Methyl-alpha-ethylaminopentiophenone (4-MEAP)[20] |
| 7446 | 4'-Methyl-alpha-pyrrolidinohexiophenone (MPHP)[20] |
| 7548 | alpha-Pyrrolidinoheptaphenone (PV8)[20] |
| 7443 | 4-Chloro-alpha-pyrrolidinovalerophenone (4-chloro-α-PVP)[20] |
| 1233 | 3-Fluoro-N-methylcathinone (3-FMC; 1-(3-fluorophenyl)-2-(methylamino)propan-1-one) |
| 1238 | 4-Fluoro-N-methylcathinone (4-FMC, flephedrone, 1-(4-fluorophenyl)-2-(methylamino)propan-1-one) |
| 1246 | Pentedrone (α-methylaminovalerophenone, 2-(methylamino)-1-phenylpentan-1-one) |
| 1249 | 4-Methyl-N-ethylcathinone (4-MEC, 2-(ethylamino)-1-(4-methylphenyl)propan-1-one) |
| 1258 | Naphyrone (naphthylpyrovalerone; 1-(naphthalen-2-yl)-2-(pyrrolidin-1-yl)pentan-1-one) |
| 7498 | 4-Methyl-alphapyrrolidinopropiophenone (4-MePPP, MePPP, 4-methyl-α-pyrrolidinopropiophenone,1-(4-methylphenyl)-2-(pyrrolidin-1-yl)-propan-1-one) |
| 7541 | Butylone (bk-MBDB, 1-(1,3-benzodioxol-5-yl)-2-(methylamino)butan-1-one) |
| 7542 | Pentylone (bk-MBDP, 1-(1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1-one) |
| 7545 | alpha-pyrrolidinopentiophenone (α-PVP, α-pyrrolidinovalerophenone, 1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one) |
| 7546 | alpha-pyrrolidinobutiophenone (α-PBP, 1-phenyl-2-(pyrrolidin-1-yl)butan-1-one) |
Cannabimimetic agents
| ACSCN | Drug |
|---|---|
| 7297 | 5-(1,1-dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (CP-47,497) |
| 7298 | 5-(1,1-dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (cannabicyclohexanol or CP-47,497 C8-homolog) |
| 7118 | 1-pentyl-3-(1-naphthoyl)indole (JWH-018 and AM678) |
| 7173 | 1-butyl-3-(1-naphthoyl)indole (JWH-073) |
| 7019 | 1-hexyl-3-(1-naphthoyl)indole (JWH-019) |
| 7200 | 1-[2-(4-morpholinyl)ethyl]-3-(1-naphthoyl)indole (JWH-200) |
| 6250 | 1-pentyl-3-(2-methoxyphenylacetyl)indole (JWH-250) |
| 7081 | 1-pentyl-3-[1-(4-methoxynaphthoyl)]indole (JWH-081) |
| 7122 | 1-pentyl-3-(4-methyl-1-naphthoyl)indole (JWH-122) |
| 7398 | 1-pentyl-3-(4-chloro-1-naphthoyl)indole (JWH-398) |
| 7201 | 1-(5-fluoropentyl)-3-(1-naphthoyl)indole (AM2201) |
| 7694 | 1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole (AM694) |
| 7104 | 1-pentyl-3-[(4-methoxy)-benzoyl]indole (SR-19 and RCS-4) |
| 7008 | 1-cyclohexylethyl-3-(2-methoxyphenylacetyl)indole 7008 (SR-18 and RCS-8) |
| 7203 | 1-pentyl-3-(2-chlorophenylacetyl)indole (JWH-203) |
| 7144 | (1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone, its optical, positional, and geometric isomers, salts and salts of isomers (UR-144, 1-pentyl-3-(2,2,3,3-tetramethylcyclopropoyl)indole) |
| 7011 | [1-(5-fluoro-pentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone, its optical, positional, and geometric isomers, salts and salts of isomers (5-fluoro-UR-144, 5-F-UR-144, XLR-11, 1-(5-fluoro-pentyl)-3-(2,2,3,3-tetramethylcyclopropoyl)indole) |
| 7048 | N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide, its optical, positional, and geometric isomers, salts and salts of isomers (APINACA, AKB-48) |
| 7222 | Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate (QUPIC, PB-22)[21] |
| 7225 | Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate (5-fluoro-PB-22; 5F-PB-22)[21] |
| 7012 | N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (AB-FUBINACA)[21] |
| 7035 | N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (ADB-PINACA)[21] |
| 7031 | N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (AB-CHMINACA)[22] |
| 7023 | N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (AB-PINACA)[22] |
| 7024 | [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone (THJ-2201)[22] |
| 7034 | 2-(1-(5-Fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate (5F-ADB, 5F-MDMB-PINACA)[23] |
| 7033 | Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate (5F-AMB)[23] |
| 7049 | N-(Adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide (5F-APINACA, 5F-AKB48)[23] |
| 7010 | N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (ADB-FUBINACA)[23] |
| 7042 | Methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate (MDMB-CHMICA, MMB-CHMINACA)[23] |
| 7020 | Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate (MDMB-FUBINACA)[23] |
| 7032 | N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (MAB-CHMINACA; ADB-CHMINACA)[24] |
| 7036 | ethyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate (5F-EDMB-PINACA)[25] |
| 7041 | methyl 2-(1-(5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate (5F-MDMB-PICA)[25] |
| 7047 | N-(adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (FUB-AKB48; FUB-APINACA; AKB48 N-(4-FLUOROBENZYL))[25] |
| 7083 | 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (5F-CUMYL-PINACA; SGT-25)[25] |
| 7014 | (1-(4-fluorobenzyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl) methanone (FUB-144)[25] |
| 7021 | Methyl 2-(1-(4-fluorobenzyl)-1Hindazole-3-carboxamido)-3-methylbutanoate (FUB–AMB, MMB– FUBINACA, AMB–FUBINACA) |
| 7025 | 5F-AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide) |
| 7044 | MMB-CHMICA (AMB-CHMICA, methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3-methylbutanoate) |
| 7085 | 5F-CUMYL-P7AICA (1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1 H-pyrrolo[2,3-b]pyridine-3-carboxamide) |
| 7089 | 4-CN-CUMYL-BUTINACA (1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide, 4-cyano-CUMYL-BUTINACA, 4-CN-CUMYL BINACA, CUMYL-4CN-BINACA, SGT-78) |
| 7221 | NM-2201 (CBL2201, Naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate) |
References
- ^ a b 21 CFR 1308.11 (CSA Sched I) with changes through 77 FR 64032 (Oct 18, 2012). Retrieved September 6, 2013.
- ^ United States Code via Cornell University's Legal Information Institute. Retrieved on 2007-10-02.
- ^ Drug Enforcement Administration (DEA) (22 Jan 2002). "Title 21 — Food and Drugs Chapter 13 - Drug Abuse Prevention and Control Subchapter I — Control and Enforcement Part D — Offenses and Penalties: Sec. 841. Prohibited Acts A(a)". Archived from the original on 26 September 2009. Retrieved 23 Oct 2009.
- ^ Code of Federal Regulations, 2012-04-01
- ^ The first 8 items in the temporary section of the schedule shown on the DEA website are not included here because they are duplicates of entries in the tables above. Presumably, this is because they were made permanent and copied there at some point, but inadvertently not deleted from this temporary listing section.
- ^ Drug Enforcement Administration, Department of Justice (2017). "Schedules of Controlled Substances: Placement of Acetyl Fentanyl into Schedule I. Final order". Federal Register. 82 (108): 26349–51. PMID 28591974.
- ^ "DEA Schedules Deadly Synthetic Drug U-47700". November 10, 2016.
- ^ Drug Enforcement Administration (2015). "Schedules of Controlled Substances: Temporary Placement of Acetyl Fentanyl Into Schedule I. Final order". Fed. Regist. 80 (137): 42381–5. PMID 26189217.
- ^ Drug Enforcement Administration, Department of Justice (2016). "Schedules of Controlled Substances: Temporary Placement of Furanyl Fentanyl Into Schedule I. Final order". Fed. Regist. 81 (229): 85873–7. PMID 27906535.
- ^ Drug Enforcement Administration, Department of Justice (2017). "Schedules of Controlled Substances: Temporary Placement of Acryl Fentanyl into Schedule I. Temporary scheduling order". Federal Register. 82 (134): 32453–7. PMID 28715161.
- ^ a b c Drug Enforcement Administration, Department of Justice (2017). "Schedules of Controlled Substances: Temporary Placement of ortho-Fluorofentanyl, Tetrahydrofuranyl Fentanyl, and Methoxyacetyl Fentanyl into Schedule I. Temporary amendment; temporary scheduling order". Federal Register. 82 (206): 49504–8. PMID 29091366.
- ^ a b Drug Enforcement Administration, Department of Justice (2016). "Schedules of Controlled Substances: Temporary Placement of Butyryl Fentanyl and Beta-Hydroxythiofentanyl into Schedule I. Final order". Federal Register. 81 (92): 29492–6. PMID 27192733.
- ^ Drug Enforcement Administration, Department of Justice (2017). "Schedules of Controlled Substances: Temporary Placement of 4-Fluoroisobutyryl Fentanyl into Schedule I. Temporary scheduling order". Federal Register. 82 (84): 20544–8. PMID 28497944.
- ^ Drug Enforcement Administration, Department of Justice (2018). "Schedules of Controlled Substances: Temporary Placement of Cyclopropyl Fentanyl in Schedule I. Temporary amendment; temporary scheduling order". Federal Register. 83 (3): 469–72. PMID 29319947.
- ^ a b c d e f g Drug Enforcement Administration, Department of Justice (2018). "Schedules of Controlled Substances: Temporary Placement of Seven Fentanyl-Related Substances in Schedule I. Temporary amendment; temporary scheduling order". Federal Register. 83 (22): 4580–5. PMID 29932604.
- ^ Drug Enforcement Administration, Department of Justice (2018). "Schedules of Controlled Substances:Temporary Placement of Fentanyl-Related Substances in Schedule I. Temporary amendment; temporary scheduling order". Federal Register. 83 (25): 5188–92. PMID 29932611.
- ^ https://www.gpo.gov/fdsys/pkg/FR-2016-12-14/pdf/2016-29941.pdf [bare URL PDF]
- ^ a b c Drug Enforcement Administration (2015). "Schedules of Controlled Substances: Extension of Temporary Placement of Three Synthetic Phenethylamines in Schedule I. Final order". Fed. Regist. 80 (219): 70657–9. PMID 26567439.
- ^ "Schedules of Controlled Substances: Temporary Placement of N-Ethylpentylone in Schedule I". Drug Enforcement Administration.
- ^ a b c d e f "Schedules of Controlled Substances: Temporary Placement of N-Ethylhexedrone, α-PHP, 4-MEAP, MPHP, PV8, and 4-Chloro-α-PVP in Schedule I". Drug Enforcement Administration.
- ^ a b c d Drug Enforcement Administration, Department of Justice (Feb 10, 2014). "Schedules of controlled substances: temporary placement of four synthetic cannabinoids into Schedule I. Final order". Fed. Regist. 79 (27): 7577–7582. PMID 24605391.
- ^ a b c Drug Enforcement Administration, Department of Justice (2015). "Schedules of controlled substances: Temporary placement of three synthetic cannabinoids into schedule I. Final order". Federal Register. 80 (20): 5042–7. PMID 25730924.
- ^ a b c d e f "Schedules of Controlled Substances: Temporary Placement of Six Synthetic Cannabinoids (5F-ADB, 5F-AMB, 5F-APINACA, ADB-FUBINACA, MDMB-CHMICA and MDMB-FUBINACA) Into Schedule I". Drug Enforcement Administration.
- ^ Drug Enforcement Administration, Department of Justice (2018). "Schedules of Controlled Substances: Extension of Temporary Placement of MAB–CHMINACA in Schedule I of the Controlled Substances Act. Temporary rule; temporary scheduling order; extension". Federal Register. 83 (20): 4411–2. PMID 29461023.
- ^ a b c d e "Schedules of Controlled Substances: Temporary Placement of 5F-EDMB-PINACA, 5F-MDMB-PICA, FUB-AKB48, 5F-CUMYL-PINACA, and FUB-144 into Schedule I". Federal Register.
External links
|